Fulceri R, Bellomo G, Gamberucci A, Scott H M, Burchell A, Benedetti A
Istituto di Patologia Generale, University of Siena, Italy.
Biochem J. 1992 Sep 15;286 ( Pt 3)(Pt 3):813-7. doi: 10.1042/bj2860813.
Light-scattering measurements of osmotically induced changes in the size of rat liver microsomal vesicles pre-equilibrated in a low-osmolality buffer revealed the following. (1) The increase in extravesicular osmolality by addition of glucose 6-phosphate or mannose 6-phosphate (25 mM each) caused a rapid shrinking of microsomal vesicles. After shrinkage, a rapid swelling phase (t1/2 approx. 22 s) was present with glucose 6-phosphate but absent with mannose 6-phosphate, indicating that the former had entered microsomal vesicles, but the latter had not. (2) Almost identical results were obtained in the absence of any glucose 6-phosphate hydrolysis, i.e. with microsomes pre-treated with 100 microM-vanadate. (3) The anion-channel blocker 4,4'-di-isothiocyanostilbene-2,2'-disulphonic acid (DIDS) suppressed the glucose 6-phosphate-induced swelling phase. (4) The swelling phase was more prolonged as the glucose 6-phosphate concentration increased (t1/2 = 16 +/- 3, 22 +/- 3 and 35 +/- 4 s with 25 mM, 37.5 mM- and 50 mM-glucose 6-phosphate respectively). The behaviour of glucose-6-phosphatase activity of intact and disrupted microsomes measured in the presence of high concentrations (less than 30 mM) of substrate also indicated the saturation of the glucose 6-phosphate permeation system by extravesicular concentrations of glucose 6-phosphate higher than 20-30 mM. Additional experiments showed that vanadate-treated microsomes pre-equilibrated with 0.1 mM- and 1.0 mM-glucose 6-phosphate (and [1-14C]glucose 6-phosphate as a tracer) rapidly (t1/2 less than 20 s) released [1-14C]glucose 6-phosphate when diluted in a glucose 6-phosphate-free medium. The efflux of [1-14C]glucose 6-phosphate was largely prevented by DIDS, allowing an evaluation of the intravesicular space of glucose 6-phosphate of approx. 1.0 microliter/mg of microsomal protein.
对预先在低渗缓冲液中平衡的大鼠肝微粒体囊泡经渗透压诱导的大小变化进行光散射测量,结果如下:(1) 添加6-磷酸葡萄糖或6-磷酸甘露糖(各25 mM)使细胞外渗透压升高,导致微粒体囊泡迅速收缩。收缩后,6-磷酸葡萄糖存在快速肿胀阶段(半衰期约22秒),而6-磷酸甘露糖不存在此阶段,这表明前者进入了微粒体囊泡,而后者没有。(2) 在不存在任何6-磷酸葡萄糖水解的情况下,即使用经100 microM钒酸盐预处理的微粒体,得到了几乎相同的结果。(3) 阴离子通道阻滞剂4,4'-二异硫氰基芪-2,2'-二磺酸(DIDS)抑制了6-磷酸葡萄糖诱导的肿胀阶段。(4) 随着6-磷酸葡萄糖浓度增加,肿胀阶段延长(6-磷酸葡萄糖浓度为25 mM、37.5 mM和50 mM时,半衰期分别为16±3秒、22±3秒和35±4秒)。在高浓度(小于30 mM)底物存在下测量的完整和破碎微粒体的6-磷酸葡萄糖酶活性行为也表明,细胞外6-磷酸葡萄糖浓度高于20 - 30 mM时,6-磷酸葡萄糖渗透系统会饱和。额外实验表明,用0.1 mM和1.0 mM 6-磷酸葡萄糖(以及[1-14C]6-磷酸葡萄糖作为示踪剂)预先平衡的经钒酸盐处理的微粒体,在无6-磷酸葡萄糖的培养基中稀释时会迅速(半衰期小于20秒)释放[1-14C]6-磷酸葡萄糖。DIDS很大程度上阻止了[1-14C]6-磷酸葡萄糖的流出,从而能够评估约1.0微升/毫克微粒体蛋白的6-磷酸葡萄糖囊泡内空间。